PRIMECAP MANAGEMENT CO/CA/PRIMECAP MANAGEMENT CO/CA/

Institutional investor · Portfolio as of Q3 2023

Top Holdings331 positions

Checking export access…
Activity:

Eli Lilly and Company

23.1M$12.4B10.5%$104.89+401.65%
20 qtrssince 2018-Q4
Decreased
0

BIOGEN INC

16M$4.1B3.5%$298.84-14.00%
20 qtrssince 2018-Q4
Decreased
0

Amgen Inc.

14.7M$4B3.3%$154.26+59.25%
20 qtrssince 2018-Q4
Decreased
0

FEDEX CORP

13.1M$3.5B2.9%$117.29+71.38%
20 qtrssince 2018-Q4
Decreased
0

Microsoft Corporation

10.5M$3.3B2.8%$94.43+226.71%
20 qtrssince 2018-Q4
Decreased
0

Adobe Inc.

6M$3.1B2.6%$226.24+125.38%
20 qtrssince 2018-Q4
Decreased
0
AZNAZN
ADR

ASTRAZENECA PLC

43.9M$3B2.5%$64.10+100.42%
20 qtrssince 2018-Q4
Decreased
0

KLA Corporation

6M$2.8B2.3%$8.13+451.16%
20 qtrssince 2018-Q4
Decreased
0

Intel Corporation

74.8M$2.7B2.2%$38.49-9.17%
20 qtrssince 2018-Q4
Increased
58

MICRON TECHNOLOGY INC

37.6M$2.6B2.2%$30.94+117.40%
20 qtrssince 2018-Q4
Decreased
0

Alphabet Inc.

19.4M$2.5B2.1%$52.04+149.10%
20 qtrssince 2018-Q4
Decreased
0

Texas Instruments Incorporated

15.8M$2.5B2.1%$76.19+91.54%
20 qtrssince 2018-Q4
Decreased
0

Tesla, Inc.

9.1M$2.3B1.9%$19.31+1195.70%
20 qtrssince 2018-Q4
Decreased
0

Boston Scientific Corporation

37.4M$2B1.7%$35.74+47.75%
20 qtrssince 2018-Q4
Decreased
0
SONYSONY
ADR

SONY GROUP CORP

22.7M$1.9B1.6%$9.26+76.26%
20 qtrssince 2018-Q4
Decreased
0

Wells Fargo & Company

43.7M$1.8B1.5%$36.98+2.74%
20 qtrssince 2018-Q4
Decreased
0

Alphabet Inc.

12.9M$1.7B1.4%$51.29+154.63%
20 qtrssince 2018-Q4
Decreased
0

BIOMARIN PHARMACEUTICAL INC

18.4M$1.6B1.4%$84.70+4.47%
20 qtrssince 2018-Q4
Increased
50

SPLUNK INC

11.1M$1.6B1.4%——
20 qtrssince 2018-Q4
Decreased
0

Thermo Fisher Scientific Inc.

3M$1.5B1.3%$222.42+125.38%
20 qtrssince 2018-Q4
Decreased
0
$118.5B
AUM
331
Positions
Q3 2023
Filing
HI score · 3.0/5
Quarterly 13F Value Change
-16%Q2'22$111.9B-8%Q3'22$103.3B+6%Q4'22$109.2B+5%Q1'23$114.7B+4%Q2'23$119.7B-1%Q3'23$118.5B
Activity profile
$ moved · Q3'23
New1%Increased10%Decreased88%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.7 years
<1Q3%1-4Q6%1-2Y8%2Y+84%

PRIMECAP MANAGEMENT CO/CA/ manages $118.5B across 331 positions as of Q3 2023. Top holdings: LLY (10.5%), BIIB (3.5%), AMGN (3.3%). Fund DNA: Steady Compounder. HoldingsIntel Score: 3/5.0.

Q3 2023 Summary

Active quarter - 10 new positions, 7 exits, 59 increased. Top move: INTC (INCREASED, conviction 58). Portfolio: $118.5B across 331 positions.

Top holdings by portfolio weight

Total AUM$118B
LLY10.46%
BIIB3.47%
AMGN3.34%
FDX2.92%
MSFT2.79%
ADBE2.60%
AZN2.51%
KLAC2.33%
INTC2.24%
MU2.16%
Other2.14%

Portfolio allocation by GICS sector

Sectors11
Healthcare31.28%
Technology27.74%
Industrials11.41%
Consumer Cyclical9.34%
Financial Services6.89%
Communication Services5.81%
Unknown5.27%
Energy0.93%
Basic Materials0.86%
Consumer Defensive0.46%
Other0.02%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Healthcare, Technology, Industrials
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(3.0 / 5.0)
Holdings P&L69
Conviction36
Concentration64
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
COPCOPConocoPhillips
Q4 2024 → Q2 2026+7.3M shares+$749.8M
7Q
SCHWSCHWCharles Schwab Corp
Q4 2024 → Q2 2026+24.1M shares+$2.3B
7Q
USFDUSFDUS FOODS HLDG CORP
Q4 2024 → Q2 2026+3.7M shares+$389.3M
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used